Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 5;13(11):1967.
doi: 10.3390/diagnostics13111967.

Imaging Criteria for the Diagnosis of Progressive Supranuclear Palsy: Supportive or Mandatory?

Affiliations

Imaging Criteria for the Diagnosis of Progressive Supranuclear Palsy: Supportive or Mandatory?

Nicoleta Lupascu et al. Diagnostics (Basel). .

Abstract

We present the case of a 54-year-old male, without any significant medical history, who insidiously developed speech disturbances and walking difficulties, accompanied by backward falls. The symptoms progressively worsened over time. The patient was initially diagnosed with Parkinson's disease; however, he failed to respond to standard therapy with Levodopa. He came to our attention for worsening postural instability and binocular diplopia. A neurological exam was highly suggestive of a Parkinson-plus disease, most likely progressive supranuclear gaze palsy. Brain MRI was performed and revealed moderate midbrain atrophy with the characteristic "hummingbird" and "Mickey mouse" signs. An increased MR parkinsonism index was also noted. Based on all clinical and paraclinical data, a diagnosis of probable progressive supranuclear palsy was established. We review the main imaging features of this disease and their current role in diagnosis.

Keywords: Magnetic Resonance Parkinsonism Index (MRPI); Mickey mouse sign; PSP syndromes; corticobasal degeneration; hummingbird sign; midbrain atrophy; morning glory sign; multiple system atrophy (MSA); postmortem histopathological examination; progressive supranuclear palsy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
T1-weighted sagittal MRI revealing the superior margin of the midbrain (yellow arrows). Notice the convex superior margin of the midbrain that could be seen in 2019 (A) and the concave appearance in 2022 (B), the so-called “hummingbird” sign.
Figure 2
Figure 2
T2-weighted axial MRI revealing the midbrain margins (yellow arrows). Notice the normal-appearing midbrain that could be seen in 2019 (A) and the atrophic midbrain with concave lateral margins (“morning glory” sign) and reduced anteroposterior diameter (“Mickey mouse” sign) which was seen in 2022 (B).
Figure 3
Figure 3
MRI FLAIR in coronal (A) and sagittal (B,C) planes. MR Parkinsonism Index (MRPI) in our patient is calculated by determining the: (A) width of the superior cerebellar peduncle (SCP) (blue line), (B) width of the middle cerebellar peduncle (MCP) (blue line), and (C) pons-to-midbrain area ratio (P/M) (red square/green square). MRPI = (P/M) × (MCP/SCP). A value higher than 13.55 is in-dicative of PSP (as was the case with our patient).

Similar articles

Cited by

References

    1. Allan H.R., Martin A.S., Joshua P.K., Sashank P., editors. Adams and Victor’s Principles of Neurology. McGraw-Hill Educational; New York, NY, USA: 2019. Chapter 38: Degenerative Diseases of the Nervous System; pp. 1118–1121.
    1. Williams D.R. Chapter 14: Progressive Supranuclear Palsy and Corticobasal Degeneration. In: Burn D.J., editor. Oxford Textbook of Movement Disorders. Oxford University Press; Oxford, UK: 2013. pp. 139–149.
    1. Höglinger G.U., Respondek G., Stamelou M., Kurz C., Josephs K.A., Lang A.E., Mollenhauer B., Müller U., Nilsson C., Whitwell J.L., et al. Movement Disorder Society-endorsed PSP Study Group. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Mov. Disord. 2017;32:853–864. doi: 10.1002/mds.26987. - DOI - PMC - PubMed
    1. Rowe J.B., Holland N., Rittman T. Progressive supranuclear palsy: Diagnosis and management. Pract. Neurol. 2021;21:376–383. doi: 10.1136/practneurol-2020-002794. - DOI - PMC - PubMed
    1. Ambrosetto P. CT in progressive supranuclear palsy. AJNR Am. J. Neuroradiol. 1987;8:849–851. doi: 10.1111/j.1600-0404.1985.tb00922.x. - DOI - PMC - PubMed

LinkOut - more resources